Qualigen Therapeutics Stock (NASDAQ:QLGN), Quotes and News Summary

Q: What sector and industry does Qualigen Therapeutics (QLGN) operate in?

Qualigen Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Qualigen Therapeutics Stock (NASDAQ: QLGN) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 65.766K
Day Range	- - -
52 Wk Range	0.283 - 1.260
Market Cap	$1.829M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	1.27%
Days to Cover	1

Recent News

Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket

Shares of Richardson Electronics, Ltd. (NASDAQ: RELL) fell sharply in today’s pre-market trading after the company posted weaker-than-expected results for its second quarter.

Avi Kapoor

Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday.

Lisa Levin

Why GameStop Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket

Gainers

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About Qualigen Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treat...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Qualigen Therapeutics (QLGN) stock?

You can purchase shares of Qualigen Therapeutics (NASDAQ: QLGN) through any online brokerage.

View our list of the best stock brokerages.

Who are Qualigen Therapeutics's (QLGN) competitors?

Other companies in Qualigen Therapeutics’s space includes: Dermata Therapeutics (NASDAQ:DRMA), NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).

What is the target price for Qualigen Therapeutics (QLGN) stock?

There is no analysis for Qualigen Therapeutics.

Current Stock Price for Qualigen Therapeutics (QLGN)?

The stock price for Qualigen Therapeutics (NASDAQ: QLGN) is $0.29 last updated April 18, 2024 at 9:08 AM EDT.

Does Qualigen Therapeutics (QLGN) pay a dividend?

There are no upcoming dividends for Qualigen Therapeutics.

When is Qualigen Therapeutics (NASDAQ:QLGN) reporting earnings?

Qualigen Therapeutics’s Q1 earnings are confirmed for Tuesday, May 14, 2024.

Is Qualigen Therapeutics (QLGN) going to split?

There is no upcoming split for Qualigen Therapeutics.

What sector and industry does Qualigen Therapeutics (QLGN) operate in?

Qualigen Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-